Coho Partners Ltd. cut its stake in Colgate-Palmolive (NYSE:CL – Free Report) by 35.6% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 89,121 shares of the company’s stock after selling 49,184 shares during the period. Coho Partners Ltd.’s holdings in Colgate-Palmolive were worth $8,102,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors also recently bought and sold shares of the stock. Chicago Partners Investment Group LLC lifted its stake in Colgate-Palmolive by 16.2% during the 4th quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock valued at $591,000 after acquiring an additional 943 shares during the period. Peak Financial Advisors LLC purchased a new position in shares of Colgate-Palmolive during the 4th quarter valued at approximately $1,315,000. Gordian Advisors LLC purchased a new position in shares of Colgate-Palmolive during the 3rd quarter valued at approximately $602,000. Carrera Capital Advisors increased its holdings in shares of Colgate-Palmolive by 23.1% during the 3rd quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock valued at $4,066,000 after purchasing an additional 7,353 shares in the last quarter. Finally, Fiduciary Alliance LLC purchased a new position in shares of Colgate-Palmolive during the 4th quarter valued at approximately $4,066,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several equities analysts have recently weighed in on the stock. Raymond James reaffirmed an “outperform” rating and set a $105.00 target price (down from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. Barclays cut their price target on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. Wells Fargo & Company cut their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. TD Cowen dropped their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a report on Wednesday, January 8th. Finally, UBS Group dropped their target price on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a report on Monday, February 3rd. One analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat, Colgate-Palmolive currently has an average rating of “Hold” and a consensus price target of $101.16.
Colgate-Palmolive Stock Up 1.3 %
Shares of CL opened at $87.87 on Friday. The stock has a market capitalization of $71.79 billion, a PE ratio of 24.96, a P/E/G ratio of 4.12 and a beta of 0.44. Colgate-Palmolive has a 1 year low of $82.83 and a 1 year high of $109.30. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.26 and a current ratio of 0.41. The company’s 50-day simple moving average is $89.83 and its 200-day simple moving average is $96.54.
Colgate-Palmolive (NYSE:CL – Get Free Report) last released its earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter last year, the business earned $0.87 EPS. Analysts forecast that Colgate-Palmolive will post 3.73 earnings per share for the current fiscal year.
Colgate-Palmolive Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be issued a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.28%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s payout ratio is currently 56.82%.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Read More
- Five stocks we like better than Colgate-Palmolive
- The Basics of Support and Resistance
- Biotechs on the Brink: 2 Stocks With Huge Potential
- Canadian Penny Stocks: Can They Make You Rich?
- Silicon Valley’s Sleeping Giant? Intel’s Comeback in Focus
- How to Effectively Use the MarketBeat Ratings Screener
- Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.